Amylin Pharmaceuticals, Inc. - Financial and Strategic Analysis Review

Amylin Pharmaceuticals, Inc. - Financial and Strategic Analysis Review

Amylin Pharmaceuticals, Inc. (Amylin Pharmaceuticals) is a biopharmaceutical company. The company is principally engaged in the development and marketing of innovative medicines for the treatment of diabetes, obesity and other diseases. The BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection are the two medicines marketed by the company to treat diabetes. Its products are sold through a network of wholesale distributors. Amylin Pharmaceuticals products are sold to healthcare providers, managed healthcare organizations, wholesalers and pharmacies, government purchasers and other third-party payors. The company is headquartered in California, United States.

Global Markets Direct's Amylin Pharmaceuticals, Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Amylin Pharmaceuticals, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

• Provides key company information for business intelligence needs.
• The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and financial and strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitor's weaknesses and target the market opportunities available to them.
• Compare your company's financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

• List of Tables
• List of Figures
  • Key Facts
  • Business Description
  • Major Products and Services
  • History
  • SWOT Analysis
  • SWOT Analysis - Overview
  • Amylin Pharmaceuticals, Inc. - Strengths
  • Amylin Pharmaceuticals, Inc. - Strengths - Performance of BYETTA
  • Amylin Pharmaceuticals, Inc. - Strengths - Research Activities
  • Amylin Pharmaceuticals, Inc. - Strengths - Collaborative Agreements
  • Amylin Pharmaceuticals, Inc. - Weaknesses
  • Amylin Pharmaceuticals, Inc. - Weaknesses - Manufacturing Capability
  • Amylin Pharmaceuticals, Inc. - Weaknesses - Limited Customers
  • Amylin Pharmaceuticals, Inc. - Opportunities
  • Amylin Pharmaceuticals, Inc. - Opportunities - Growing Market for Diabetes
  • Amylin Pharmaceuticals, Inc. - Opportunities - Development Programs
  • Amylin Pharmaceuticals, Inc. - Opportunities - Amylinomimetics
  • Amylin Pharmaceuticals, Inc. - Opportunities - Emerging Markets
  • Amylin Pharmaceuticals, Inc. - Opportunities - Rising Healthcare Expenditure in the US
  • Amylin Pharmaceuticals, Inc. - Threats
  • Amylin Pharmaceuticals, Inc. - Threats - Tightening of the FDA's Regulatory Oversight
  • Amylin Pharmaceuticals, Inc. - Threats - Increased Pricing Control
  • Amylin Pharmaceuticals, Inc. - Threats - Impact of Financial Crisis
  • Key Competitors
  • Key Employees
  • Key Employee Biographies
  • Locations And Subsidiaries
  • Locations And Subsidiaries - Head Office
  • Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
• Appendix
  • Methodology
  • Ratio Definitions
  • About Global Markets Direct
  • Contact Us
  • Disclaimer
• List of Tables
  • Amylin Pharmaceuticals, Inc., Key Facts
  • Major Products and Services
  • Amylin Pharmaceuticals, Inc., History
  • Amylin Pharmaceuticals, Inc., Key Employees
  • Amylin Pharmaceuticals, Inc., Key Employee Biographies
  • Amylin Pharmaceuticals, Inc., Ratios based on current share price
  • Amylin Pharmaceuticals, Inc., Annual Ratios
  • Amylin Pharmaceuticals, Inc., Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
• List of Figures
  • Amylin Pharmaceuticals, Inc., Ratio Charts